Umbilical Cord Blood Treatment Abroad in Spain is priced per case at 1 hospital. The operation takes 2 to 3 days, with 4 to 5 days in hospital. Each hospital quotes its own price for your case.
Hospitals and clinics offering Umbilical Cord Blood Treatment Abroad in Spain
Umbilical Cord Blood Treatment Abroad is listed by 1 hospital in Spain. The order reshuffles every hour so each gets equal exposure.
Quirón has an internationally prestigious medical staff, the largest in the sector, and is also the principal hospital network in terms of patient numbers and care facility area. The group administers 47 healthcare centers, more than 4.000 hospital beds and 8.000 doctors
Description of Umbilical Cord Blood Treatment Abroad:
How is the procedure performed?
Our regenerative procedure involves the intravenous infusion
of donated cord blood cells in an out-patient setting. In order to maximize
therapeutic effect, a dose of greater than 50 million cord blood cells per kg
of body weight from 4 to 8 donors is infused in each procedure, and the cord
blood infusions are generally administered over the course of 2 to 3 days
(about 3 hours/day). During and after each infusion, patients are attended by
doctors and medical staff for close monitoring.
Success Rates
CBC Health AG treatment with high-dose of donated umbilical
cord blood cells shows response rates of about 85% in patients within first two
years after onset of cerebral ischemia. Cord blood regenerative therapy results
in improvement on neurological and functional levels. The sooner the cord blood
treatment is applied in parallel with neurorehabilitation, the better the
clinical outcome.
Key facts to plan your treatment: how long it takes, your hospital stay, anaesthesia, risks and recovery.
Duration of surgery/treatment
After one day of thorough clinical examination, the cord blood infusions are generally administered over the course of 2 to 3 days in an out-patient setting. The day after the treatment a final check-
Days admitted
4 - 5 days max.
Recovery
Patients begin to notice improvements within a few weeks after the infusion. The cord blood cells are eliminated from the patient’s body within 6 to 8 weeks; however, patients experience functional gains over the next 3 to 6 months, with sustained functional improvement. Achieved improvement is permanent; patients do not experience worsening of the achieved improvement. Repeated cord blood infusions might lead to further functional benefits.
Risks
Low rate of potential side effects, such as
- constipation
- diarrhea
- pruritus
- headache
- hypertension
- varied tastes
- allergic reactions
Almost all of these reactions are only short-term and mostly related to DMSO (Dimethylsulfoxide), a cryoprotective agent that is dissolved rapidly in the patient’s body. Pre-medication including anti-histamines before the umbilical cord blood treatment significantly reduces the frequency as well as the intensity of these potential side effects.
After care
After completion of our therapy and being back home, we recommend subsequent neurorehabilitation (physical therapy, occupational therapy, etc.) for at least next 2 – 3 months. The synergy of cord blood regenerative chemistry and neurorehabilitation will boost neuroplasticity and post-stroke brain repair.
In addition, our doctors will be in contact with patient over the next 6 months to monitor treatment effectiveness and any potential adverse effects.